Lancet issues correction on study that led WHO to pause HCQ trial
London, May 30, Medial journal The Lancet issued a correction on a large observational study that linked use of anti-malarial drug hydroxychloroquine with increased death risk in Covid-19 patients, after more than 100 scientists and medical…